Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study

Douglas Tremblay; Maaike Van Gerwen; Mathilda Alsen; Santiago Thibaud; Alaina Kessler; Sangeetha Venugopal; Iman Makki; Qian Qin; Sirish Dharmapuri; Tomi Jun; Sheena Bhalla; Shana Berwick; Jonathan Feld; John Mascarenhas; Kevin Troy; Caroline Cromwell; Andrew Dunn; William K. Oh; Leonard Naymagon

doi:10.1182/BLOOD.2020006941

Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study

Douglas Tremblay, Maaike Van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Kessler, Sangeetha Venugopal, Iman Makki, Qian Qin, Sirish Dharmapuri, Tomi Jun, Sheena Bhalla, Shana Berwick, Jonathan Feld, John Mascarenhas, Kevin Troy, Caroline Cromwell, Andrew Dunn, William K. Oh, Leonard Naymagon

Research output: Contribution to journal › Letter › peer-review

114 Scopus citations

Original language	English (US)
Pages (from-to)	144-147
Number of pages	4
Journal	Blood
Volume	136
Issue number	1
DOIs	https://doi.org/10.1182/BLOOD.2020006941
State	Published - Jul 2020
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/BLOOD.2020006941

Cite this

Tremblay, D., Van Gerwen, M., Alsen, M., Thibaud, S., Kessler, A., Venugopal, S., Makki, I., Qin, Q., Dharmapuri, S., Jun, T., Bhalla, S., Berwick, S., Feld, J., Mascarenhas, J., Troy, K., Cromwell, C., Dunn, A., Oh, W. K., & Naymagon, L. (2020). Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study. Blood, 136(1), 144-147. https://doi.org/10.1182/BLOOD.2020006941

Tremblay, D, Van Gerwen, M, Alsen, M, Thibaud, S, Kessler, A, Venugopal, S, Makki, I, Qin, Q, Dharmapuri, S, Jun, T, Bhalla, S, Berwick, S, Feld, J, Mascarenhas, J, Troy, K, Cromwell, C, Dunn, A, Oh, WK & Naymagon, L 2020, 'Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study', Blood, vol. 136, no. 1, pp. 144-147. https://doi.org/10.1182/BLOOD.2020006941

@article{7b4b77b6f5db4091bdc3b80fcefe3522,

title = "Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study",

author = "Douglas Tremblay and {Van Gerwen}, Maaike and Mathilda Alsen and Santiago Thibaud and Alaina Kessler and Sangeetha Venugopal and Iman Makki and Qian Qin and Sirish Dharmapuri and Tomi Jun and Sheena Bhalla and Shana Berwick and Jonathan Feld and John Mascarenhas and Kevin Troy and Caroline Cromwell and Andrew Dunn and Oh, {William K.} and Leonard Naymagon",

note = "Funding Information: Conflict-of-interest disclosure: J.M. has received research funding from CTI Biopharma. A.D. has received research funding from Pfizer/Bristol-Myers Squibb, served on the scientific advisory board for Bristol-Myers Squibb, and received an honorarium from Johnson & Johnson. W.K.O. has acted as a consultant for Astellas, AstraZeneca, Bayer, Janssen, Sanofi, Sema4, and TeneoBio. The remaining authors declare no competing financial interests.",

year = "2020",

month = jul,

doi = "10.1182/BLOOD.2020006941",

language = "English (US)",

volume = "136",

pages = "144--147",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Impact of anticoagulation prior to COVID-19 infection

T2 - A propensity score-matched cohort study

AU - Tremblay, Douglas

AU - Van Gerwen, Maaike

AU - Alsen, Mathilda

AU - Thibaud, Santiago

AU - Kessler, Alaina

AU - Venugopal, Sangeetha

AU - Makki, Iman

AU - Qin, Qian

AU - Dharmapuri, Sirish

AU - Jun, Tomi

AU - Bhalla, Sheena

AU - Berwick, Shana

AU - Feld, Jonathan

AU - Mascarenhas, John

AU - Troy, Kevin

AU - Cromwell, Caroline

AU - Dunn, Andrew

AU - Oh, William K.

AU - Naymagon, Leonard

N1 - Funding Information: Conflict-of-interest disclosure: J.M. has received research funding from CTI Biopharma. A.D. has received research funding from Pfizer/Bristol-Myers Squibb, served on the scientific advisory board for Bristol-Myers Squibb, and received an honorarium from Johnson & Johnson. W.K.O. has acted as a consultant for Astellas, AstraZeneca, Bayer, Janssen, Sanofi, Sema4, and TeneoBio. The remaining authors declare no competing financial interests.

PY - 2020/7

Y1 - 2020/7

UR - http://www.scopus.com/inward/record.url?scp=85087530711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087530711&partnerID=8YFLogxK

U2 - 10.1182/BLOOD.2020006941

DO - 10.1182/BLOOD.2020006941

M3 - Letter

C2 - 32462179

AN - SCOPUS:85087530711

SN - 0006-4971

VL - 136

SP - 144

EP - 147

JO - Blood

JF - Blood

IS - 1

ER -

Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this